Kiniksa Pharmaceuticals International, plc

By person

20 insiders · 190 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Patel Sanj K

CHAIRMAN & CEO

—

$56.69M (39) scheduled

−$56.69M

1,205,731

$96.82M

+364.0%

BAKER BROS. ADVISORS LP entity

Director

$54.00M (2)

—

+$54.00M

2,759,734

$221.61M

—

Tessari Eben

CHIEF STRATEGY OFFICER

—

$19.65M (34) scheduled

−$19.65M

23,130

$1.86M

−78.4%

Flynn James E

10% owner

$16.00M (4)

—

+$16.00M

843,352

$67.72M

—

Paolini John F.

CHIEF MEDICAL OFFICER

—

$14.04M (30) scheduled

−$14.04M

69,922

$5.61M

+5,641%

Ragosa Mark

CHIEF FINANCIAL OFFICER

—

$12.46M (24) scheduled

−$12.46M

20,854

$1.67M

+190.5%

Malley Thomas

Director

—

$5.86M (3) scheduled

−$5.86M

87,312

$7.01M

—

Moat Ross

CHIEF OPERATING OFFICER

—

$5.83M (11) scheduled

−$5.83M

16,307

$1.31M

+208.5%

Megna Michael R

CHIEF ACCOUNTING OFFICER

—

$5.70M (15) scheduled

−$5.70M

29,062

$2.33M

+1,736%

Quart Barry D

Director

—

$3.87M (12) scheduled

−$3.87M

12,745

$1.02M

—

Beetham Thomas W.

EVP & Chief Legal Officer

—

$2.11M (8)

−$2.11M

297,523

$23.89M

+306.5%

Cormorant Asset Management, LP entity

10% owner

$1.25M (1)

—

+$1.25M

1,731,442

$139.03M

+108.4%

Cole G Bradley

Director

—

$299.09K (1)

−$299.09K

7,172

$575.91K

—

Mahoney Stephen F.

President & COO

—

79,589

$6.39M

+8.7%

BOESS CARSTEN

10% owner

—

79,589

$6.39M

+8.7%

Heberlig Chris

EVP & CFO

—

42,991

$3.45M

+17.5%

Levy Richard S

Director

—

22,359

$1.80M

—

Popovits Kimberly J

Director

—

15,345

$1.23M

—

McCain Tracey L

Director

—

15,345

$1.23M

—

Rizvi Qasim

Chief Commercial Officer

—

5,176

$415.63K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Megna Michael R

3 Sep 2026

CHIEF ACCOUNTING OFFICER

Sold on a plan

4,600

$80.30

$369.38K

Moat Ross

9 Apr 2026

CHIEF OPERATING OFFICER

Sold on a plan

1,703

$46.69

$79.51K

Megna Michael R

9 Apr 2026

CHIEF ACCOUNTING OFFICER

Sold on a plan

6,625

$46.69

$309.32K

Moat Ross

6 Apr 2026

CHIEF OPERATING OFFICER

Sold on a plan

2,367

$48.58

$114.99K

Ragosa Mark

8 Jan 2026

CHIEF FINANCIAL OFFICER

Sold on a plan

12,000

$41.89

$502.68K

Moat Ross

4 Sep 2025

CHIEF CORP. & COMM. OFFICER

Sold on a plan

3,523

$35.31

$124.40K

Moat Ross

21 Apr 2025

CHIEF COMMERCIAL OFFICER

Sold on a plan

18,259

$20.29

$370.48K

Patel Sanj K

7 Mar 2024

CHAIRMAN & CEO

Sold on a plan indirect

65,012

$21.02

$1.37M

Patel Sanj K

6 Mar 2024

CHAIRMAN & CEO

Sold on a plan indirect

5,582

$21.00

$117.22K

Patel Sanj K

4 Mar 2024

CHAIRMAN & CEO

Sold on a plan indirect

3,336

$22.00

$73.39K

Patel Sanj K

4 Mar 2024

CHAIRMAN & CEO

Sold on a plan indirect

9,406

$21.31

$200.44K

Show all 190 transactions →

Kiniksa Pharmaceuticals International, plc

By person

Individual transactions

What was left out